Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway

Cardiovascular Research

Volumn 72, Issue 1, 2006, Pages 152-162

  Zhu, Min ^a   Feng, Jianhua ^a   Lucchinetti, Eliana ^a   Fischer, Gregor ^b   Xu, Lin ^a   Pedrazzini, Thierry ^c   Schaub, Marcus C ^b   Zaugg, Michael ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c University of Lausanne Medical Center   (Switzerland)

Author keywords

Cardiac remodeling; Cellular signaling; Ischemia reperfusion injury; Postconditioning; Reperfusion injury salvage kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; S6 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLIP; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HYPERTENSION; IN VITRO STUDY; INOTROPISM; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TARGET CELL; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; ENZYME ACTIVATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ONCOGENE PROTEIN V-AKT; PERFUSION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUBULIN; VENTRICULAR REMODELING;

EID: 33748177384     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.06.027     Document Type: Article

References (27)

1. Kloner R.A., and Rezkalla S.H. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res 70 (2006) 297-307
2. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579-H588
3. Bose A.K., Mocanu M.M., Carr R.D., and Yellon D.M. Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model. Cardiovasc Drugs Ther 19 (2005) 9-11
4. Feng J., Lucchinetti E., Ahuja P., Pasch T., Perriard J.C., and Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3β. Anesthesiology 103 (2005) 987-995
5. Yang X.M., Krieg T., Cui L., Downey J.M., and Cohen M.V. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 36 (2004) 411-421
6. Hausenloy D.J., Tsang A., and Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15 (2005) 69-75
7. Ferdinandy P., Szilvassy Z., and Baxter G.F. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon?. Trends Pharmacol Sci 19 (1998) 223-229
8. Feng J., Fischer G., Lucchinetti E., Zhu M., Bestmann L., Jegger D., et al. Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning - role of protein-kinase-B/Akt signaling. Anesthesiology 104 (2006) 1004-1014
9. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., et al. Myocardial infarct size and ventricular function in rats. Circ Res 44 (1979) 503-512
10. Wiesel P., Mazzolai L., Nussberger J., and Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 29 (1997) 1025-1030
11. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44 (2004) 1103-1110
12. Yang X.M., Philipp S., Downey J.M., and Cohen M.V. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 100 (2005) 57-63
13. Darling C.E., Jiang R., Maynard M., Whittaker P., Vinten-Johansen J., and Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 289 (2005) H1618-H1626
14. Schwartz L.M., and Lagranha C.J. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 290 (2006) H1011-H1018
15. Iliodromitis E.K., Zoga A., Vrettou A., Andreadou I., Paraskevaidis I.A., Kaklamanis L., et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis (2005) [Electronic publication ahead of print Dec 22]
16. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'Huillier I., et al. Postconditioning the human heart. Circulation 112 (2005) 2143-2148
17. Schaper J., Froede R., Hein S., Buck A., Hashizume H., Speiser B., et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83 (1991) 504-514
18. Neubauer S., Horn M., Naumann A., Tian R., Hu K., Laser M., et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest 95 (1995) 1092-1100
19. Dorn II G.W., and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115 (2005) 527-537
20. Opie L.H., Commerford P.J., Gersh B.J., and Pfeffer M.A. Controversies in ventricular remodelling. Lancet 367 (2006) 356-367
21. Miyamoto T., Takeishi Y., Takahashi H., Shishido T., Arimoto T., Tomoike H., et al. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload. Basic Res Cardiol 99 (2004) 328-337
22. Nagoshi T., Matsui T., Aoyama T., Leri A., Anversa P., Li L., et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115 (2005) 2128-2138
23. Miki T., Miura T., Tsuchida A., Nakano A., Hasegawa T., Fukuma T., et al. Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. Circulation 102 (2000) 458-463
24. Pantos C.I., Davos C.H., Carageorgiou H.C., Varonos D.V., and Cokkinos D.V. Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts. Basic Res Cardiol 91 (1996) 444-449
25. Boutros A., and Wang J. Ischemic preconditioning, adenosine and bethanechol protect spontaneously hypertensive isolated rat hearts. J Pharmacol Exp Ther 275 (1995) 1148-1156
26. Randall M.D., Gardiner S.M., and Bennett T. Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2) 27) hypertensive rat. Cardiovasc Res 33 (1997) 400-409
27. Speechly-Dick M.E., Baxter G.F., and Yellon D.M. Ischaemic preconditioning protects hypertrophied myocardium. Cardiovasc Res 28 (1994) 1025-1029